LoadingLoadingLoadingThe quick read
Latest quote·Oct 14
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Solventum Corp. (SOLV) insiders filed no open-market purchases or sales in the 90 days to Oct 18, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a SOLV trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position.
Buys/Adds (2)
Millennium
$57.3M
added
D.E. Shaw
$31.1M
added
Sells/Trims (1)
Citadel
$31.5M
trimmed
Sells (1)
No tracked top-trader positions in SOLV right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 5, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.91 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $2.55 / $1.91Alpha Vantage | +33.51% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $1.48 / $1.35Alpha Vantage | +9.63% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 26, 2026 | $1.57 / $1.50Alpha Vantage | +4.67% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $1.50 / $1.43Alpha Vantage | +4.90% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $1.69 / $1.45Alpha Vantage | +16.55% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $1.34 / $1.22Alpha Vantage | +9.84% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 27, 2025 | $1.41 / $1.50Alpha Vantage | -6.00% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | $1.64 / $1.39Alpha Vantage | +17.99% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 18, 2026
EPS expected
$1.29 to $1.43
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.10B | $2.00B | $2.01B | $2.21B |
| Cost of what it sold | $919.0M | $1.01B | $910.0M | $923.0M |
| Gross profit | $1.18B | $985.0M | $1.10B | $1.29B |
| What it spent | ||||
| Research and development | $183.0M | $176.0M | $189.0M | $178.0M |
| Sales and admin | $780.0M | $759.0M | $827.0M | $927.0M |
| Other operating costs | $77.0M | -$1.63B | — | — |
| Total operating expenses | $1.04B | -$693.0M | $1.02B | $1.10B |
| What was left | ||||
| Operating profit | $137.0M | $1.68B | $81.0M | $181.0M |
| Interest on debt | $89.0M | $51.0M | $62.0M | $64.0M |
| Profit before tax | $1.51B | $58.0M | $16.0M | $108.0M |
| Tax | $248.0M | -$5.0M | $3.0M | $15.0M |
| Net profit | $1.27B | $63.0M | $13.0M | $92.0M |
| EBITDA | $1.72B | $226.0M | $213.0M | $305.0M |
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Precision Trading with Solventum Corporation When-issued (SOLV) Risk Zones
BullishOct 17Solventum Corp. stock falls Friday, underperforms market
BearishOct 16SOLN5759824 Bond Profile: Coupon and Redemption
NeutralOct 16If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
NeutralOct 16SOLN5957968 Bond Profile: Coupon and Redemption
NeutralOct 16At 4:30 p.m. Eastern on Nov. 5, Solventum will discuss its quarterly results.
NeutralOct 15Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
NeutralOct 15Solventum Corp. stock rises Wednesday, outperforms market
BullishOct 14